Physician profile
Mark D Bej
NPI 1427040914
$27,982.27
in general payments reported to CMS, 2019-2025
66 companies · $4,602 in 2025
The $4,602 reported for 2025 was more than what 84% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,607 · 2020: $3,445 · 2021: $3,472 · 2022: $3,984 · 2023: $2,135 · 2024: $3,736 · 2025: $4,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $150 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,207.35 |
| Consulting Fee | $150.00 |
| Education | $116.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $4,444.47 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Jazz Pharmaceuticals INC. | $1,853.36 | 2019-2025 | |
| Livanova USA, INC. | $1,772.67 | 2019-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Abbvie INC. | $1,629.26 | 2020-2025 | Ubrelvy, Qulipta, Duopa |
| Ucb, INC. | $1,538.21 | 2019-2025 | Fintepla, Briviact, Nayzilam |
| Sk Life Science, INC. | $1,500.83 | 2020-2025 | Xcopri |
| Lilly USA, LLC | $1,250.21 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Lundbeck LLC | $1,068.01 | 2019-2025 | Vyepti, Rexulti |
| Eisai INC. | $943.92 | 2019-2025 | |
| Amgen INC. | $847.09 | 2019-2023 | Aimovig |
| Biohaven Pharmaceuticals, INC. | $773.68 | 2021 | |
| Genzyme Corporation | $717.05 | 2019-2025 | |
| Harmony Biosciences LLC | $699.95 | 2020-2025 | Wakix |
| E.R. Squibb & Sons, L.L.C. | $696.31 | 2020-2025 | Zeposia |
| Neurelis, INC. | $617.57 | 2020-2025 | Valtoco |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bej listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.